3Simom LS,Lanza FL,Lipsky PE,et al.Preliminary study of safety and efficacy of Sc-58635,a novel cyclcoxygenase2-inhibitor:efficacy and rheumatoid arthritis,and studies of gastrointestinel and platelet effects[J].Arthritis Rheum,1998,41(9):1591-1602.
4Scott DL.Advances in the medical management of rheumatoid arthritis[J].Hosp Med,2002,63 (5):294-297.
5Conn DL.New role for an old friend:prednisone is a disease.modifying agent in early rheumatoid arthritis[J].Current Opinion in Rheumatology,2003,15:193-196.
6Boers M.The validity of radiography as outcome measure in rheumatoid arthritis[J].Rheumatol,1995,22:1783.
7Aringer M,Graninger WB.Treating rheumatoid arthritis with new disease modifying drugs[J].Acta Med Austriaca,2002,29(1):33-35.
9Kavanaugh AF,Davis LS,Nichols LA,et al.Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule-1 (ICAM-1)[J].Arthritis Rheum,1994,37:992-999.
10Barnes DA,Tse J,Kaufhold M,et al.Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model[J].J Clin Invest,1998,101(12):2910-2919.
